Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. (SHE:300937)
China flag China · Delayed Price · Currency is CNY
34.12
+0.14 (0.41%)
At close: Feb 27, 2026

SHE:300937 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Net Income
-5.9316.3659.5342.026.454.02
Depreciation & Amortization
29.7729.7724.3723.8516.5710.04
Other Amortization
10.0810.086.123.061.921.4
Loss (Gain) From Sale of Assets
0.610.610.050.080.110.06
Asset Writedown & Restructuring Costs
-0.4-0.40.0120.146.465.72
Loss (Gain) From Sale of Investments
1.841.84-1.544.29-7.52-0.18
Provision & Write-off of Bad Debts
6.046.049.89---
Other Operating Activities
-109.920.2919.460.482.150.22
Change in Accounts Receivable
-2.48-2.48-30.26-18.43-73.83-49.33
Change in Inventory
34.7734.77-117.318.95-133.44-45.63
Change in Accounts Payable
21.0621.06-79.4362.628.8893.82
Operating Cash Flow
-24.78127.69-115.47152.67-154.3869.32
Operating Cash Flow Growth
-----63.74%
Capital Expenditures
-21.13-32.21-35.33-18.32-31.43-35.22
Sale of Property, Plant & Equipment
0.950.670.540.080.016.33
Cash Acquisitions
-0.09-0.090.0720.89--0.08
Divestitures
-1.13.030.33-0.09-
Investment in Securities
-22.11-19.73-7.72-13.68-100.62-2.39
Other Investing Activities
0.670.65-95.640.320.190.63
Investing Cash Flow
-41.71-49.62-135.04-10.39-131.93-30.72
Short-Term Debt Issued
-457.5330.5185.42130.240.05
Total Debt Issued
424.58457.5330.5185.42130.240.05
Short-Term Debt Repaid
--454-195.42-119.2-51-40
Long-Term Debt Repaid
--8.42-6.26-5.88-3.79-
Total Debt Repaid
-367.22-462.42-201.68-125.08-54.79-40
Net Debt Issued (Repaid)
57.35-4.92128.8260.3475.410.05
Common Dividends Paid
-16.48-30.25-24.12-5.31-20.67-12.64
Other Financing Activities
-7.990.32.712.16272.060.25
Financing Cash Flow
32.88-34.88107.4257.18326.8-12.34
Foreign Exchange Rate Adjustments
00-0-0--
Net Cash Flow
-33.6143.2-143.1199.4740.4926.25
Free Cash Flow
-45.9195.48-150.8134.35-185.8134.1
Free Cash Flow Growth
-----479.04%
Free Cash Flow Margin
-1.05%2.18%-3.40%3.38%-5.46%1.22%
Free Cash Flow Per Share
-0.480.99-1.571.41-2.030.47
Cash Income Tax Paid
70.555865.3644.3830.7841.66
Levered Free Cash Flow
64.275.51-195.93177.55-201.21-0.94
Unlevered Free Cash Flow
69.6211.58-191.82181.57-200.070.2
Change in Working Capital
43.1343.13-233.3758.74-180.48-1.97
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.